Dionex has announced a method that the company reports can fully recover low concentrations of three microcystins when added to water samples.
Dionex has announced a method that the company reports can fully recover low concentrations (
Microcystin contamination of drinking water at low nanomolar concentrations is considered a risk factor for cancer; therefore, the World Health Organization (WHO) has proposed a provisional guideline concentration of 1.0 μg/L for microcystin-LR in drinking water.
The company’s Application Note 261: Sensitive Determination of Microcystins in Drinking and Environmental Waters is reported to demonstrate recovery at lower concentrations than the maximum recommended by WHO. The company claims that this method is fully automated and easily configured on an UltiMate 3000 ×2 Dual HPLC system, using Acclaim PA2 columns for solid-phase extraction (SPE) and analysis.
This new target-cut on-line SPE method with dual function (analyte capture and partial separation) operates under automatic control of Chromeleon Chromatography Data System (CDS) software and offers full automation, absence of operator influence and strict process control.
For the application note, click here.
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.